|
ES2217967B1
(es)
*
|
2003-03-31 |
2006-01-01 |
Consejo Sup. Investig. Cientificas |
Procedimiento de produccion de particulas virales vacias (vlps) del virus inductor de la bursitis infecciosa (ibdv), composiciones necesarias para su puesta a punto y su uso en la elaboracion de vacunas frente al ibdv.
|
|
US8206950B2
(en)
*
|
2003-06-09 |
2012-06-26 |
Animal Technology Institute Taiwan |
Fusion antigen used as vaccine and method of making them
|
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
|
US8506967B2
(en)
*
|
2003-07-11 |
2013-08-13 |
Novavax, Inc. |
Functional influenza virus like particles (VLPs)
|
|
US8080255B2
(en)
|
2003-07-11 |
2011-12-20 |
Novavax Inc. |
Functional influenza virus like particles (VLPs)
|
|
US8551756B2
(en)
|
2003-07-11 |
2013-10-08 |
Novavax, Inc. |
Avian influenza chimeric VLPS
|
|
US8992939B2
(en)
*
|
2003-07-11 |
2015-03-31 |
Novavax, Inc. |
Highly efficient influenza matrix (M1) proteins
|
|
US20160000902A1
(en)
*
|
2003-07-11 |
2016-01-07 |
Novavax, Inc. |
Combination vaccine for respiratory syncytial virus and influenza
|
|
ES2307346B1
(es)
*
|
2004-01-21 |
2009-11-13 |
Consejo Sup. Investig. Cientificas |
Capsidas vacias (vlps(-vp4)) del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones.
|
|
ES2307345B1
(es)
*
|
2004-01-21 |
2009-11-13 |
Consejo Sup. Investig. Cientificas |
Capsidas vacias quimericas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones.
|
|
GB0716992D0
(en)
|
2007-08-31 |
2007-10-10 |
Immune Targeting Systems Its L |
Influenza antigen delivery vectors and constructs
|
|
GB0408164D0
(en)
|
2004-04-13 |
2004-05-19 |
Immune Targeting Systems Ltd |
Antigen delivery vectors and constructs
|
|
US20090208517A1
(en)
*
|
2004-08-19 |
2009-08-20 |
Bernhard Moser |
Preparation Of Antigen-Presenting Human Gamma-Delta T Cells And Use In Immunotherapy
|
|
ATE476497T1
(de)
*
|
2004-08-19 |
2010-08-15 |
Univ Cardiff |
Präparation antigenpräsentierender menschlicher gamma delta t-zellen und verwendung in der immuntherapie
|
|
WO2006089001A2
(en)
*
|
2005-02-16 |
2006-08-24 |
Lentigen Corporation |
Lentiviral vectors and their use
|
|
NZ562661A
(en)
|
2005-04-21 |
2010-04-30 |
Univ Florida |
Materials and methods for respiratory disease control in canines
|
|
ES2310062B1
(es)
*
|
2005-07-15 |
2009-11-13 |
Bionostra, S.L. |
Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.
|
|
US8338173B2
(en)
*
|
2005-08-11 |
2012-12-25 |
University College Cardiff Consultants Limited |
Preparation of antigen-presenting human γδ T cells and use in immunotherapy
|
|
AU2006304640B2
(en)
*
|
2005-10-18 |
2012-10-11 |
Novavax, Inc. |
Functional influenza virus like particles (VLPs)
|
|
CA2626489C
(en)
|
2005-10-19 |
2020-10-27 |
University Of Florida Research Foundation, Inc |
Materials and methods for respiratory disease control in canines
|
|
WO2008048269A2
(en)
*
|
2005-10-20 |
2008-04-24 |
Combimatrix Corporation |
Microarray for pathogen identification
|
|
GB2432419A
(en)
*
|
2005-11-16 |
2007-05-23 |
Agency Science Tech & Res |
Influenza A virus detection method
|
|
FI20051255A0
(fi)
*
|
2005-12-05 |
2005-12-05 |
Pekka Untamo Heino |
Seuraavaa influenssa A-pandemiaa vastaan soveltuva rokote
|
|
US8232058B2
(en)
*
|
2006-01-20 |
2012-07-31 |
Lawrence Livermore National Security, Llc |
Multiplex detection of respiratory pathogens
|
|
EP1988919A4
(en)
*
|
2006-02-02 |
2009-06-10 |
Globeimmune Inc |
VAKZINE ON YEAST BASE FOR TRIGGERING AN IMMUNE RESPONSE
|
|
GB0613977D0
(en)
*
|
2006-02-07 |
2006-08-23 |
Peptcell Ltd |
Peptide sequences and compositions
|
|
EP2476432B1
(en)
|
2006-03-07 |
2015-08-19 |
Vaxinnate Corporation |
Compositions that include hemagglutinin, methods of making and methods of use thereof
|
|
WO2007126788A2
(en)
*
|
2006-03-27 |
2007-11-08 |
Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods and compositions for the treatment and prevention of viral infection
|
|
US20070243587A1
(en)
*
|
2006-04-14 |
2007-10-18 |
Healthbanks Biotech Co., Ltd. |
Using a reverse genetic engineering platform to produce protein vaccines and protein vaccine of avian influenza virus
|
|
WO2007130330A2
(en)
*
|
2006-05-01 |
2007-11-15 |
Technovax, Inc. |
Polyvalent influenza virus-like particle (vlp) compositions
|
|
WO2007130327A2
(en)
|
2006-05-01 |
2007-11-15 |
Technovax, Inc. |
Influenza virus-like particle (vlp) compositions
|
|
US20100143393A1
(en)
*
|
2006-05-11 |
2010-06-10 |
Gale Smith |
Novel influenza m2 vaccines
|
|
KR100702034B1
(ko)
*
|
2006-05-12 |
2007-03-30 |
삼성전자주식회사 |
반도체 장치, 이 장치의 전원 노이즈 감소 방법 및 인쇄회로 기판
|
|
EP2043681B1
(en)
|
2006-07-14 |
2015-10-07 |
Sanofi Pasteur Biologics, LLC |
Construction of recombinant virus vaccines by direct transposon-mediated insertion of foreign immunologic determinants into vector virus proteins
|
|
EP2044224A4
(en)
*
|
2006-07-27 |
2011-04-13 |
Ligocyte Pharmaceuticals Inc |
CHIMERIC VIRUS TYPE PARTICLES
|
|
US9439959B2
(en)
|
2006-07-27 |
2016-09-13 |
Takeda Vaccines, Inc. |
Chimeric influenza virus-like particles
|
|
US8080645B2
(en)
|
2007-10-01 |
2011-12-20 |
Longhorn Vaccines & Diagnostics Llc |
Biological specimen collection/transport compositions and methods
|
|
US9481912B2
(en)
|
2006-09-12 |
2016-11-01 |
Longhorn Vaccines And Diagnostics, Llc |
Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
|
|
US8097419B2
(en)
|
2006-09-12 |
2012-01-17 |
Longhorn Vaccines & Diagnostics Llc |
Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
|
|
US8652782B2
(en)
|
2006-09-12 |
2014-02-18 |
Longhorn Vaccines & Diagnostics, Llc |
Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids
|
|
US20090098527A1
(en)
*
|
2006-09-12 |
2009-04-16 |
Fischer Gerald W |
Biological organism identification product and methods
|
|
WO2008100290A2
(en)
|
2006-09-29 |
2008-08-21 |
Sanofi Pasteur Biologics Co |
Recombinant rhinovirus vectors
|
|
AU2008302276B2
(en)
|
2006-09-29 |
2013-10-10 |
Takeda Vaccines, Inc. |
Method of conferring a protective immune response to norovirus
|
|
EP2601970B1
(en)
|
2006-09-29 |
2016-10-26 |
Takeda Vaccines, Inc. |
Norovirus vaccine formulations
|
|
WO2008058396A1
(en)
*
|
2006-11-15 |
2008-05-22 |
Folia Biotech Inc. |
Papaya mosaic virus-based vaccines for influenza
|
|
US8877206B2
(en)
|
2007-03-22 |
2014-11-04 |
Pds Biotechnology Corporation |
Stimulation of an immune response by cationic lipids
|
|
CA2615372A1
(en)
|
2007-07-13 |
2009-01-13 |
Marc-Andre D'aoust |
Influenza virus-like particles (vlps) comprising hemagglutinin
|
|
EP2175883A4
(en)
*
|
2007-07-19 |
2011-11-30 |
Novavax Inc |
CHIMERIC VARICELLA ZOSTER VIRUS-VIRUSUAL PARTICLES
|
|
US9683256B2
(en)
|
2007-10-01 |
2017-06-20 |
Longhorn Vaccines And Diagnostics, Llc |
Biological specimen collection and transport system
|
|
US11041215B2
(en)
|
2007-08-24 |
2021-06-22 |
Longhorn Vaccines And Diagnostics, Llc |
PCR ready compositions and methods for detecting and identifying nucleic acid sequences
|
|
US10004799B2
(en)
|
2007-08-27 |
2018-06-26 |
Longhorn Vaccines And Diagnostics, Llc |
Composite antigenic sequences and vaccines
|
|
EP2772267B1
(en)
*
|
2007-08-27 |
2016-04-27 |
Longhorn Vaccines and Diagnostics, LLC |
Immunogenic compositions and methods
|
|
US20100266636A1
(en)
|
2007-09-18 |
2010-10-21 |
Ligocyte Pharmaceuticals, Inc. |
Method of conferring a protective immune response to norovirus
|
|
US11041216B2
(en)
|
2007-10-01 |
2021-06-22 |
Longhorn Vaccines And Diagnostics, Llc |
Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
|
|
AU2008343745B2
(en)
|
2007-10-01 |
2012-05-10 |
Longhorn Vaccines & Diagnostics Llc |
Biological specimen collection and transport system and methods of use
|
|
NZ587108A
(en)
|
2007-11-27 |
2013-04-26 |
Medicago Inc |
Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
|
|
KR101956910B1
(ko)
*
|
2008-01-21 |
2019-03-12 |
메디카고 인코포레이티드 |
헤마글루티닌을 발현하는 트랜스제닉 식물에서 생산된 재조합 인플루엔자 바이러스-유사 입자(ＶＬＰｓ)
|
|
WO2009102229A1
(ru)
*
|
2008-02-15 |
2009-08-20 |
A.N. Belozersky Institute Of Physico-Chemical Biology, Moscow State University |
Липид-протеиновый рафтовый комплекс из оболочки вируса гриппа а для противогриппозных вакцин и способ его выделения, способ получения вирусоподобных частиц из таких комплексов
|
|
US9789129B2
(en)
|
2008-04-17 |
2017-10-17 |
Pds Biotechnology Corporation |
Stimulation of an immune response by enantiomers of cationic lipids
|
|
WO2009128951A2
(en)
|
2008-04-18 |
2009-10-22 |
Vaxinnate Corporation |
Compositions of respiratory synctial virus proteins and methods of use
|
|
EP2286223B1
(en)
*
|
2008-05-02 |
2016-07-06 |
University Of Rochester |
Arrayed detector system for measurement of influenza immune response
|
|
US8450056B2
(en)
*
|
2008-05-02 |
2013-05-28 |
University Of Rochester |
Arrayed imaging reflectometry (AIR) sensor chip comprising virus-like particles suitable for the detection of antiviral immune responses
|
|
CN101293099B
(zh)
*
|
2008-06-04 |
2010-12-08 |
厦门大学 |
一种抗多种亚型禽流感病毒的多肽疫苗及其制备方法
|
|
EP2294202B1
(en)
|
2008-07-08 |
2015-05-20 |
Medicago Inc. |
Soluble recombinant influenza antigens
|
|
JP5813505B2
(ja)
*
|
2008-07-18 |
2015-11-17 |
メディカゴ インコーポレイテッド |
新規インフルエンザウイルス免疫エピトープ
|
|
US20110206727A1
(en)
*
|
2008-07-30 |
2011-08-25 |
Denis Leclerc |
Multivalent Vaccines Based on Papaya Mosaic Virus and Uses Thereof
|
|
IT1394782B1
(it)
|
2009-03-03 |
2012-07-13 |
Alenia Aeronautica Spa |
Procedimento di predizione di collisioni tra un velivolo e un aeromobile
|
|
JP2012521786A
(ja)
|
2009-03-30 |
2012-09-20 |
モウント シナイ スクール オフ メディシネ |
インフルエンザウイルスワクチン及びその使用
|
|
SG10201603033QA
(en)
*
|
2009-05-01 |
2016-05-30 |
Pfizer |
Recombinant virus-like particles encoded by multi-gene vector
|
|
CA2800182A1
(en)
*
|
2009-05-26 |
2010-12-02 |
Mount Sinai School Of Medicine |
Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
|
|
JP5871796B2
(ja)
|
2009-06-24 |
2016-03-01 |
メディカゴ インコーポレイテッド |
ヘマグルチニンを含むキメラインフルエンザウイルス様粒子
|
|
ES2566361T3
(es)
|
2009-07-02 |
2016-04-12 |
Massachusetts Institute Of Technology |
Composiciones y métodos para diagnosticar y/o tratar una infección gripal
|
|
RU2579903C2
(ru)
|
2009-09-22 |
2016-04-10 |
Медикаго Инк. |
Способ получения вирусоподобных частиц растений
|
|
US20110097358A1
(en)
*
|
2009-10-12 |
2011-04-28 |
Techno Vax, Inc. |
RESPIRATORY SYNCYTIAL VIRUS (RSV) VIRUS-LIKE PARTICLES (VLPs)
|
|
CN102753582A
(zh)
|
2009-11-03 |
2012-10-24 |
莱戈赛特医药股份有限公司 |
嵌合RSV-F多肽、和慢病毒或α-反转录病毒GAG基VLP
|
|
WO2011103453A2
(en)
|
2010-02-18 |
2011-08-25 |
Mount Sinai School Of Medicine |
Vaccines for use in the prophylaxis and treatment of influenza virus disease
|
|
JP2013520167A
(ja)
|
2010-02-18 |
2013-06-06 |
テクノヴァックス，インコーポレイテッド |
万能ウイルス様粒子（ｖｌｐ）インフルエンザワクチン
|
|
AU2011224245B2
(en)
|
2010-03-11 |
2014-12-04 |
Immune Design Corp. |
Vaccines for influenza
|
|
US10130697B2
(en)
|
2010-03-23 |
2018-11-20 |
Wisconsin Alumni Research Foundation (Warf) |
Vaccines comprising mutant attenuated influenza viruses
|
|
CN102939103A
(zh)
|
2010-03-30 |
2013-02-20 |
西奈山医学院 |
流感病毒疫苗及其应用
|
|
WO2012019168A2
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
CN102373184A
(zh)
*
|
2010-08-09 |
2012-03-14 |
中山大学 |
禽流感和传染性支气管炎混合病毒样颗粒、制备方法和应用
|
|
CN102373182A
(zh)
*
|
2010-08-09 |
2012-03-14 |
中山大学 |
禽流感和传染性囊病混合病毒样颗粒、制备方法和应用
|
|
WO2012040406A2
(en)
|
2010-09-21 |
2012-03-29 |
Massachusetts Institute Of Technology |
Influenza treatment and/or characterization; human-adapted ha polypeptides; vaccines
|
|
ES3005233T3
(en)
|
2010-10-01 |
2025-03-14 |
Modernatx Inc |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
|
SG189236A1
(en)
|
2010-10-04 |
2013-05-31 |
Massachusetts Inst Technology |
Hemagglutinin polypeptides, and reagents and methods relating thereto
|
|
CA2817005C
(en)
*
|
2010-11-05 |
2018-09-11 |
Novavax Inc. |
Rabies glycoprotein virus-like particles (vlps)
|
|
SG191295A1
(en)
*
|
2010-12-22 |
2013-07-31 |
Novavax Inc |
Modified influenza hemagglutinin proteins and uses thereof
|
|
TWI526539B
(zh)
*
|
2010-12-22 |
2016-03-21 |
苜蓿股份有限公司 |
植物中生產類病毒顆粒(vlp)的方法及以該方法生產之vlp
|
|
TWI620816B
(zh)
|
2011-03-23 |
2018-04-11 |
苜蓿股份有限公司 |
植物衍生蛋白回收方法
|
|
DE12722942T1
(de)
|
2011-03-31 |
2021-09-30 |
Modernatx, Inc. |
Freisetzung und formulierung von manipulierten nukleinsäuren
|
|
CN103732749B
(zh)
*
|
2011-06-20 |
2017-03-29 |
高等教育联邦系统-匹兹堡大学 |
计算优化的宽反应性的h1n1流感抗原
|
|
BR112014000656A2
(pt)
|
2011-07-11 |
2017-02-14 |
Takeda Vaccines Inc |
formulações de vacina parenteral contra norovírus
|
|
US9683020B2
(en)
|
2011-08-01 |
2017-06-20 |
Emory University |
VLPS containing ligands and methods related thereto
|
|
EP3275464A1
(en)
|
2011-08-01 |
2018-01-31 |
Emory University |
Vlps containing ligands and methods related thereto
|
|
EP2747778B1
(en)
|
2011-08-26 |
2017-12-06 |
Wisconsin Alumni Research Foundation |
Influenza viruses with mutant pb2 gene segment as live attenuated vaccines
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP2758075B1
(en)
|
2011-09-20 |
2023-05-03 |
Icahn School of Medicine at Mount Sinai |
Influenza virus vaccines and uses thereof
|
|
RU2648950C2
(ru)
|
2011-10-03 |
2018-04-02 |
Модерна Терапьютикс, Инк. |
Модифицированные нуклеозиды, нуклеотиды и нуклеиновые кислоты и их применение
|
|
AU2012352180A1
(en)
|
2011-12-16 |
2014-07-31 |
Moderna Therapeutics, Inc. |
Modified nucleoside, nucleotide, and nucleic acid compositions
|
|
CA3207612A1
(en)
|
2012-01-26 |
2013-08-01 |
Longhorn Vaccines And Diagnostics, Llc |
Composite antigenic sequences and vaccines
|
|
RU2653756C2
(ru)
|
2012-02-07 |
2018-05-14 |
Юниверсити Оф Питтсбург - Оф Зе Коммонвэлс Систем Оф Хайе Эдьюкейшн |
Оптимизированные с помощью компьютера антигены с широким спектром реактивности для вирусов гриппа h3n2
|
|
JP6175452B2
(ja)
|
2012-02-13 |
2017-08-02 |
ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション |
ヒトおよびトリｈ５ｎ１インフルエンザのための、計算で最適化した反応性の広い抗原
|
|
RU2485973C1
(ru)
*
|
2012-02-28 |
2013-06-27 |
Общество с ограниченной ответственностью "НТфарма" |
Рекомбинантная трехвалентная вакцина от гриппа человека
|
|
IN2014DN07152A
(cg-RX-API-DMAC7.html)
|
2012-03-22 |
2015-04-24 |
Fraunhofer Usa Inc |
|
|
MY166953A
(en)
|
2012-03-30 |
2018-07-25 |
Univ Pittsburgh Commonwealth Sys Higher Education |
Computationally optimized broadly reactive antigens for h5n1 and h1n1 influenza viruses
|
|
WO2013151663A1
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of membrane proteins
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
US9938324B2
(en)
|
2012-05-22 |
2018-04-10 |
Cornell University |
FRET-based reagents and methods for identifying anti-HIV compounds
|
|
EP3632464A1
(en)
|
2012-06-15 |
2020-04-08 |
PDS Biotechnology Corporation |
Cationic lipid vaccine compositions and methods of use
|
|
US8932598B2
(en)
|
2012-08-28 |
2015-01-13 |
Vaxinnate Corporation |
Fusion proteins and methods of use
|
|
EP4091630A1
(en)
*
|
2012-09-21 |
2022-11-23 |
PDS Biotechnology Corporation |
Vaccines comprising r-dotap
|
|
KR101484588B1
(ko)
|
2012-10-24 |
2015-01-20 |
대한민국 |
개 인플루엔자 ｖｌｐ 백신의 제조방법
|
|
HRP20220607T1
(hr)
|
2012-11-26 |
2022-06-24 |
Modernatx, Inc. |
Terminalno modificirana rna
|
|
AU2013352179B2
(en)
|
2012-11-27 |
2017-12-21 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Computationally optimized broadly reactive antigens for H1N1 influenza
|
|
SG11201504728RA
(en)
|
2012-12-18 |
2015-07-30 |
Icahn School Med Mount Sinai |
Influenza virus vaccines and uses thereof
|
|
EP2971010B1
(en)
|
2013-03-14 |
2020-06-10 |
ModernaTX, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
|
US9908930B2
(en)
|
2013-03-14 |
2018-03-06 |
Icahn School Of Medicine At Mount Sinai |
Antibodies against influenza virus hemagglutinin and uses thereof
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
ME03590B
(me)
|
2013-08-13 |
2020-07-20 |
Univ Northwestern |
Čestice konjugovane peptidom
|
|
CN103467581B
(zh)
*
|
2013-08-26 |
2016-01-20 |
中国科学院微生物研究所 |
流感病毒m1蛋白及其编码基因和应用
|
|
EP3041934A1
(en)
|
2013-09-03 |
2016-07-13 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
|
EP3041938A1
(en)
|
2013-09-03 |
2016-07-13 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
|
EP3052106A4
(en)
|
2013-09-30 |
2017-07-19 |
ModernaTX, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
KR20160067219A
(ko)
|
2013-10-03 |
2016-06-13 |
모더나 세라퓨틱스, 인코포레이티드 |
저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드
|
|
DK3092309T3
(da)
|
2014-01-10 |
2021-04-12 |
Medicago Inc |
Cpmv-forstærkerelementer
|
|
ES3009962T3
(en)
|
2014-04-23 |
2025-03-31 |
Modernatx Inc |
Nucleic acid vaccines
|
|
US11273127B2
(en)
|
2014-05-06 |
2022-03-15 |
The Regents Of The University Of Colorado, A Body Corporate |
Compositions, methods and uses for thermally stable multi-targeted antigens
|
|
WO2015196150A2
(en)
|
2014-06-20 |
2015-12-23 |
Wisconsin Alumni Research Foundation (Warf) |
Mutations that confer genetic stability to additional genes in influenza viruses
|
|
WO2016010081A1
(ja)
*
|
2014-07-18 |
2016-01-21 |
一般財団法人化学及血清療法研究所 |
ウイルス様粒子を含むワクチン
|
|
JP2018504412A
(ja)
|
2015-01-23 |
2018-02-15 |
アイカーン スクール オブ メディシン アット マウント サイナイ |
インフルエンザウイルスワクチン接種レジメン
|
|
KR101745472B1
(ko)
|
2015-04-15 |
2017-06-12 |
대한민국 |
조류인플루엔자 바이러스의 세포 감염을 저해하는 물질을 선별하는 방법
|
|
WO2016183292A1
(en)
|
2015-05-14 |
2016-11-17 |
Longhorn Vaccines And Diagnostics, Llc |
Rapid methods for the extraction of nucleic acids from biological samples
|
|
JP2018530314A
(ja)
|
2015-08-28 |
2018-10-18 |
ウィスコンシン アルムニ リサーチ ファンデイション |
ウイルス様粒子からの感染性インフルエンザウイルスの生成
|
|
KR102758377B1
(ko)
|
2015-09-03 |
2025-01-23 |
노바백스, 인코포레이티드 |
개선된 안정성 및 면역원성을 갖는 백신 조성물
|
|
US10391163B2
(en)
*
|
2015-09-10 |
2019-08-27 |
Academia Sinica |
Bird flu vaccine combination comprising virus-like particles and novel adjuvants
|
|
US11612652B2
(en)
|
2015-11-13 |
2023-03-28 |
Pds Biotechnology Corporation |
Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy
|
|
EP3417056A1
(en)
|
2016-02-19 |
2018-12-26 |
Wisconsin Alumni Research Foundation (WARF) |
Improved influenza b virus replication for vaccine development
|
|
CN109641041A
(zh)
|
2016-06-15 |
2019-04-16 |
西奈山伊坎医学院 |
流感病毒血细胞凝集素蛋白及其用途
|
|
EP3606555A4
(en)
|
2017-04-07 |
2021-08-04 |
Icahn School of Medicine at Mount Sinai |
INFLUENZA VIRUS TYPE B ANTI-NEURAMINIDASE ANTIBODIES AND THEIR USES
|
|
EP3625246A1
(en)
|
2017-05-18 |
2020-03-25 |
ModernaTX, Inc. |
Polynucleotides encoding tethered interleukin-12 (il12) polypeptides and uses thereof
|
|
EP4074734A1
(en)
|
2017-08-04 |
2022-10-19 |
The Hospital for Sick Children |
Nanoparticle platform for antibody and vaccine delivery
|
|
CN107353328A
(zh)
*
|
2017-08-23 |
2017-11-17 |
上海市动物疫病预防控制中心 |
一种重组的h9n2亚型禽流感病毒样颗粒及其制备方法和用途
|
|
CN107488216B
(zh)
*
|
2017-09-06 |
2020-11-10 |
中国人民解放军军事医学科学院微生物流行病研究所 |
一种流感病毒通用疫苗及其制备方法与应用
|
|
JP2021500891A
(ja)
|
2017-10-25 |
2021-01-14 |
ウィスコンシン アルムニ リサーチ ファンデイション |
卵における複製のための安定化されたｈａを有する組換えインフルエンザウイルス
|
|
CN110240634B
(zh)
*
|
2018-03-08 |
2022-09-06 |
普莱柯生物工程股份有限公司 |
一种禽流感病毒样颗粒疫苗、及其制备方法和应用
|
|
CN110575538B
(zh)
*
|
2018-06-11 |
2022-08-19 |
普莱柯生物工程股份有限公司 |
一种禽流感病毒样颗粒疫苗、及其制备方法和应用
|
|
US12364746B2
(en)
|
2018-06-21 |
2025-07-22 |
Icahn School Of Medicine At Mount Sinai |
Mosaic influenza virus hemagglutinin polypeptides and uses thereof
|
|
US12343390B2
(en)
|
2018-08-07 |
2025-07-01 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant biologically contained filovirus vaccine
|
|
US11389523B2
(en)
|
2018-08-20 |
2022-07-19 |
Wisconsin Alumni Research Foundation (Warf) |
Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (HA) protein
|
|
CN109097341B
(zh)
*
|
2018-08-28 |
2021-09-24 |
青岛农业大学 |
一种同时表达ha和hef的复制缺陷型重组流感病毒
|
|
EP3851120A4
(en)
|
2018-09-11 |
2022-04-27 |
Shanghai Public Health Clinical Center |
Immunogen for broad-spectrum influenza vaccine and application thereof
|
|
EP3921413A1
(en)
|
2019-02-08 |
2021-12-15 |
Wisconsin Alumni Research Foundation (WARF) |
Humanized cell line
|
|
CN114929269A
(zh)
|
2019-05-01 |
2022-08-19 |
威斯康星校友研究基金会(Warf) |
用于疫苗开发的改进的流感病毒复制
|
|
WO2021041624A2
(en)
|
2019-08-27 |
2021-03-04 |
Yoshihiro Kawaoka |
Recombinant influenza viruses with stabilized ha for replication in eggs
|
|
US11739303B2
(en)
|
2020-01-24 |
2023-08-29 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant influenza viruses with stabilized NA
|
|
WO2021195410A1
(en)
|
2020-03-25 |
2021-09-30 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant multivalent influenza viruses
|
|
CN113461786B
(zh)
*
|
2020-03-30 |
2022-09-13 |
普莱柯生物工程股份有限公司 |
一种禽流感病毒样颗粒疫苗、及其制备方法和应用
|
|
CN113403343A
(zh)
*
|
2021-04-30 |
2021-09-17 |
吉林大学 |
一种h3n2与h9n2亚型禽流感二价嵌合型病毒样颗粒的制备
|
|
CN113398259A
(zh)
*
|
2021-04-30 |
2021-09-17 |
吉林大学 |
一种h9n2亚型禽流感新型标记疫苗的制备方法及其应用
|